Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia
Main Authors: | Burnett, A, Russell, N, Hills, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Hematology
2016
|
Similar Items
-
Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01) -
CPX-351 in FLT3-mutated acute myeloid leukemia
by: Claire Andrews, et al.
Published: (2023-11-01) -
Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic disease.
by: Mead, A, et al.
Published: (2008) -
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
by: Abhishek Maiti, et al.
Published: (2021-02-01) -
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
by: Naval Daver, et al.
Published: (2021-05-01)